2196 — Shanghai Fosun Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$32.76bn
- HK$67.46bn
- CNY41.40bn
Annual cashflow statement for Shanghai Fosun Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -13,570 | -12,871 | -15,073 | -18,042 | -19,590 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,222 | 2,580 | 3,949 | 4,218 | 3,414 |
| Capital Expenditures | -3,962 | -4,437 | -4,973 | -5,889 | -5,337 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3,790 | -269 | 1,116 | 1,825 | 1,517 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -172 | -4,706 | -3,857 | -4,064 | -3,819 |
| Financing Cash Flow Items | 2,369 | 1,048 | -727 | 3,055 | -911 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,936 | 1,467 | -831 | 4,428 | -1,336 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,109 | -959 | -874 | 4,710 | -1,668 |